Cargando…

An angiogenic factor isolated from tumours: a potent low-molecular-weight compound.

Detalles Bibliográficos
Autores principales:	Weiss, J. B., Brown, R. A., Kumar, S., Phillips, P.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1979
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010045/ https://www.ncbi.nlm.nih.gov/pubmed/508574

Ejemplares similares

Stimulation by a low-molecular-weight angiogenic factor of capillary endothelial cells in culture.
por: Schor, A. M., et al.
Publicado: (1980)

Identification of a Potent Endothelium-Derived Angiogenic Factor
por: Jankowski, Vera, et al.
Publicado: (2013)

Molecular Mechanisms of Resistance to Tumour Anti-Angiogenic Strategies
por: Grépin, Renaud, et al.
Publicado: (2010)

Correction: Identification of a Potent Endothelium-Derived Angiogenic Factor
por: Jankowski, Vera, et al.
Publicado: (2013)

A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity
por: Loret, Erwann P., et al.
Publicado: (2018)

The Epidermal Growth Factor-like Domain of CD93 Is a Potent Angiogenic Factor
por: Kao, Yuan-Chung, et al.
Publicado: (2012)

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
Publicado: (1992)

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
por: Yamamoto, K, et al.
Publicado: (2012)

Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours
por: Sidibe, Adama, et al.
Publicado: (2018)

Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma
por: Jiang, Honglei, et al.
Publicado: (2017)

Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases
por: Kahlert, C, et al.
Publicado: (2014)

Searching for Low Molecular Weight Seleno-Compounds in Sprouts by Mass Spectrometry
por: Kurek, Eliza, et al.
Publicado: (2020)

Silver Nanostructured Substrates in LDI-MS of Low Molecular Weight Compounds
por: Sagandykova, Gulyaim, et al.
Publicado: (2022)

Reply: Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma' – β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs
por: Pasquier, E, et al.
Publicado: (2013)

Opticin: a potent anti-angiogenic/antiproliferative agent for breast cancer therapy
por: Sneddon, SF, et al.
Publicado: (2010)

AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR
por: Zhou, Yuanfeng, et al.
Publicado: (2012)

Comparison between Airway Responses to High versus Low Molecular Weight Compounds in Occupational Asthma
por: Talini, D., et al.
Publicado: (2011)

Marine Low Molecular Weight Natural Products as Potential Cancer Preventive Compounds
por: Stonik, Valentin A., et al.
Publicado: (2014)

Mutant p53 targeting by the low molecular weight compound STIMA‐1
por: Zache, Nicole, et al.
Publicado: (2017)

Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies
por: Yang, Zhengyang, et al.
Publicado: (2022)

Tumours modulate the systemic vascular response to anti‐angiogenic therapy
por: Hargreaves, Adam, et al.
Publicado: (2022)

Robust positive control of tumour growth using angiogenic inhibition
por: Homayounzade, Mohamadreza, et al.
Publicado: (2023)

Characterisation of Novel Angiogenic and Potent Anti-Inflammatory Effects of Micro-Fragmented Adipose Tissue
por: Guo, Baoqiang, et al.
Publicado: (2021)

Bioactivity-guided isolation of potent anxiolytic compounds from leaves of Citrus paradisi
por: Gupta, Vikas, et al.
Publicado: (2018)

An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes
por: Pinato, D J, et al.
Publicado: (2014)

Biliverdin's regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer
por: Zheng, J, et al.
Publicado: (2014)

Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
por: Babapoor-Farrokhran, Savalan, et al.
Publicado: (2015)

A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice
por: Chen, Yung-Yi, et al.
Publicado: (2013)

Anticoagulant Activity of Low-Molecular Weight Compounds from Heterometrus laoticus Scorpion Venom
por: Tran, Thien Vu, et al.
Publicado: (2017)

MALDI Matrices for the Analysis of Low Molecular Weight Compounds: Rational Design, Challenges and Perspectives
por: Qiao, Zhi, et al.
Publicado: (2021)

Utilization of low-molecular-weight organic compounds by the filterable fraction of a lotic microbiome
por: Ghuneim, Lydia-Ann J, et al.
Publicado: (2020)

Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs
por: Lipinski, Christopher A., et al.
Publicado: (2022)

New, Low–Molecular Weight Chemical Compounds Inhibiting Biological Activity of Interleukin 15
por: Krzeczyński, Piotr, et al.
Publicado: (2023)

Extraction, Isolation and Identification of Low Molecular Weight Peptides in Human Milk
por: Xiao, Hailong, et al.
Publicado: (2022)

The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
por: Debergh, I, et al.
Publicado: (2010)

Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma
por: Obad, Nina, et al.
Publicado: (2017)

Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
por: Wohlfeil, Sebastian A., et al.
Publicado: (2022)

Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours
por: Yoo, Changhoon, et al.
Publicado: (2019)

Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications
por: Stahl, Andreas, et al.
Publicado: (2012)

A Highly Pure Sub-Fraction of Shallot Extract With Potent in vitro Anti-Angiogenic Activity
por: Famil Samavati, Shima, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3iuit6q9qh21rhc9qedssnf8mm